Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized TrialHiroaki Hiraga, Toshifumi Ozaki, Yoshihiro Nishida et al.|Journal of Clinical Oncology|2025Cited by 11
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS)Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga et al.|Japanese Journal of Clinical Oncology|2024Cited by 3
A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).Makoto Endo, Toshifumi Ozaki, Kazuhiro Tanaka et al.|Journal of Clinical Oncology|2021Cited by 0
Randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs adjuvant chemotherapy alone for localized soft tissue sarcoma (NACLESS, JCOG2102).Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga et al.|Journal of Clinical Oncology|2024Cited by 0